Creating a national network of experts/stakeholders to facilitate & promote the development of Nucleic Acid Therapies for patients with rare diseases in the UK
12 PhDs on Antisense oligonucleotide #research to foster the full therapeutic potential of antisense technology across tissues https://t.co/X5zLUkVG8T
11 posts across Europe, the other at UCL under @UpNAT_node Director Haiyan Zhou @lab_zhou
UPNAT Director Haiyan Zhou is keynote speaker at the upcoming Cambridge Chem&Bio Seminar on Nucleic Acid Research. @lab_zhou@UpNAT_node
Space is available on 14 Dec "whether you're a student, researcher, or simply curious about the field", book here: https://t.co/WcajdMoLZv
Congrats to Carlo Rinaldi @rinaldi_ca, awarded title of Professor of Molecular & Translational Neuroscience @UniofOxford Institute of Developmental & Regenerative Medicine.
Carlo is @UpNAT_node PI, streamlining NAT clinical trials & regulatory approval. https://t.co/tRCk38ky5z
The Oxford-Harrington Rare Disease Centre has announced inaugural 2024 Rare Disease Scholar award recipients, which includes two members of the @UpNAT_node team. Well done Haiyan Zhou and Carlo Rinaldi on this notable achievement! @OHRareDisease@lab_zhou@rinaldi_ca@RDRUKHub
Join the @UpNAT_node team!
Applications for the Child Health Research (CHR) PhD Studentships for 25/26 are open. Deadline for students to apply is 09:00 Friday 13th December.
https://t.co/hzSqrYDSrx
An interesting paper to contextualise the recent published guidelines by the Dutch Center for RNA Therapeutics
https://t.co/sFDmf7lHEj @oligogirl@LaufferMarlen @roon_mom #raredisease
@oligogirl@timyu@UpNAT_node @BeijerDanique @aubriesoucy The guidelines are accompanied by training videos and test variants for practicing assessments. All videos are available via the N1C YouTube Channel. https://t.co/oT3wco4hji
Impressive work by the Dutch Center for RNA Therapeutics! Thanks to @LaufferMarlen for the opportunity to participate in this ASO guideline development, with @UpNAT_node co-authors @aliceedavidson and @MinaRyten https://t.co/S7HEwtVbfR #DCRT
Excellent speakers lined up for the Oxford-Harrington Rare Disease Centre Symposium later this month (including @UpNAT_node Director Haiyan Zhou)
Registration is open:
https://t.co/HeZHCRs05A
#RareDiseases@lab_zhou@OHRareDisease
Join us for an insightful webinar on "A Nucleic Acid Approach to Antibody Therapeutics" on July 18th.
Dr. John Chaput will explore innovative pathways for democratizing antibody therapeutics using threomers.
Register now: https://t.co/iE5GjinQKQ
#ots#webinar#nucleicacid
Join the @UpNAT_node team! Now hiring: our candidate will have a PhD degree in biomedical sciences or closely related areas, with strong knowledge & skillset in bioinformatics. Preclinical RNA therapy drug development (ASO, siRNA, mRNA) are highly desired. https://t.co/QTKVUOtMoR
UPNAT Director Haiyan Zhou @lab_zhou will be speaking tomorrow alongside UK DRI Director Mina Ryten @MinaRyten at the @GenomicsEngland Summit about the @UpNAT_node and enhancing rare disease treatment: https://t.co/xwLs2mFl9Z
Now to build on the momentum of the recent @UpNAT_node Symposium, with the help of our partners across the UK and beyond.
With special thanks to @OTSociety who supported PPIE at the event with their generous grant: https://t.co/Lc2Zf5NOoU
Join the @UpNAT_node team! Now hiring: our candidate will have a PhD degree in biomedical sciences or closely related areas, with strong knowledge & skillset in bioinformatics. Preclinical RNA therapy drug development (ASO, siRNA, mRNA) are highly desired. https://t.co/QTKVUOtMoR
We enjoyed excellent participation from the audience at last week's @UpNAT_node Symposium. Our two panels (1- target selection for #raredisease, and 2- #clinicaltrials and regulatory pathway) in particular generated thoughtful & useful discussion.
@RDRUKHub@The_MRC@NIHRresearch